Spyros Papapetropoulos
| Spyros Papapetropoulos | |
|---|---|
| Born | Greece |
| 🏳️ Nationality | Greek |
| 💼 Occupation | |
Spyros Papapetropoulos also known as Spyridon Papapetropoulos, is a Greek neurologist and neuroscientist. He has worked in universities, research institutions and biopharmaceutical companies in Greece, Europe, Australia and the United States.[1][2][3]
Papapetropoulos held faculty positions at the University of Miami, Miller School of Medicine and served as a Consultant at the Massachusetts General Hospital, Department of Neurology.[4][5][6]
Papapetropoulos has several patents related to drug development and has held leadership roles in biotechnology and pharmaceutical research and development.[7][8][9][10][11]
Papapetropoulos has been covered by Greek and international media, including Forbes USA.[2]
Papapetropoulos has published studies in journals such as JAMA, NEJM,British Journal of Pharmacology, and Science Translational Medicine.[12]
Selected publications
- Collaborative Analysis of α-Synuclein Gene Promoter Variability and Parkinson Disease. JAMA. 2006;296(6):661–670. doi:10.1001/jama.296.6.661.[13]
- BNC210, an α7 Nicotinic Receptor Modulator, in Post-Traumatic Stress Disorder. NEJM Evid 2025;4(1) DOI: 10.1056/EVIDoa2400380 VOL. 4 NO. 1.[14]
- Drug repurposing from the perspective of pharmaceutical companies. https://doi.org/10.1111/bph.13798.[15]
- PGC-1α, A Potential Therapeutic Target for Early Intervention in Parkinson's Disease.Sci. Transl. Med.2,52ra73-52ra73(2010).DOI:10.1126/scitranslmed.3001059.[16]
References
- ↑ "Spyros Papapetropoulos | Delphi Economic Forum X". def-x.delphiforum.gr. 2024-07-07. Retrieved 2025-11-13.
- ↑ 2.0 2.1 Nordstrom, Todd. "Stress And Anxiety: Doctor Shares 5 Steps to Boost Performance". Forbes. Retrieved 2025-11-13.
- ↑ "Australia-based Bionomics appoints new President and Chief Executive Officer". www.biospectrumasia.com. Retrieved 2025-11-19.
- ↑ "Selected Neurology Publications". Mass General Neurology faculty.
- ↑ "Meet the Company". Huntington Study Group. Retrieved 2025-11-19.
- ↑ Adams, Ben (2017-08-15). "Novartis, Lilly-backed Cavion poaches Teva executive as R&D head | Fierce Biotech". www.fiercebiotech.com. Retrieved 2025-11-19.
- ↑ "Cavion Appoints Spyridon Papapetropoulos, M.D., Ph.D. as Executive Vice President, Research and Development and Chief Medical Officer". firstwordpharma.com. Retrieved 2025-11-19.
- ↑ Adams, Ben (2017-08-15). "Novartis, Lilly-backed Cavion poaches Teva executive as R&D head | Fierce Biotech". www.fiercebiotech.com. Retrieved 2025-11-19.
- ↑ Read, 2 Min (2020-11-23). "Adamas announces changes to its Board of Directors with the appointment of Spyros Papapetropoulos and the retirement of Ivan Lieberburg". BioSpace. Retrieved 2025-11-19.
- ↑ "Bionomics appoints Spyridon "Spyros" Papapetropoulos as President and Chief Executive Officer". Finance Yahoo.
- ↑ "Lipocine Announces Senior Leadership Appointments to Advance its CNS-Focused Pipeline". Lipocine. Retrieved 2025-11-13.
- ↑ "Spyros Papapetropoulos MD, PhD – New England Hellenic Medical and Dental Society". Retrieved 2025-11-13.
- ↑ Maraganore, Demetrius M. (2006-08-09). "Collaborative Analysis of α-Synuclein Gene Promoter Variability and Parkinson Disease". JAMA. 296 (6): 661–670. doi:10.1001/jama.296.6.661. ISSN 0098-7484. PMID 16896109.
- ↑ Papapetropoulos, Spyridon; Doolin, Elizabeth; O’Connor, Susan; Paul, Dharam; Odontiadis, Michael; Jaros, Mark; Rolan, Paul; Stein, Murray B. (2025-01-01). "BNC210, an α7 Nicotinic Receptor Modulator, in Post-Traumatic Stress Disorder". NEJM Evidence. 4 (1): EVIDoa2400380. doi:10.1056/EVIDoa2400380. PMID 39647171 Check
|pmid=value (help). - ↑ Cha, Y; Erez, T; Reynolds, I J; Kumar, D; Ross, J; Koytiger, G; Kusko, R; Zeskind, B; Risso, S; Kagan, E; Papapetropoulos, S; Grossman, I; Laifenfeld, D (2018). "Drug repurposing from the perspective of pharmaceutical companies". British Journal of Pharmacology. 175 (2): 168–180. doi:10.1111/bph.13798. ISSN 1476-5381. PMC 5758385. PMID 28369768.
- ↑ Zheng, Bin; Liao, Zhixiang; Locascio, Joseph J.; Lesniak, Kristen A.; Roderick, Sarah S.; Watt, Marla L.; Eklund, Aron C.; Zhang-James, Yanli; Kim, Peter D.; Hauser, Michael A.; Grünblatt, Edna; Moran, Linda B.; Mandel, Silvia A.; Riederer, Peter; Miller, Renee M. (2010-10-06). "PGC-1α, A Potential Therapeutic Target for Early Intervention in Parkinson's Disease". Science Translational Medicine. 2 (52): 52ra73. doi:10.1126/scitranslmed.3001059. PMC 3129986. PMID 20926834.
This article "Spyros Papapetropoulos" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Spyros Papapetropoulos. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
